Streetbeat News

Stock Prices

ASRT

ATRA

INBS

OCX

Several healthcare stocks experienced significant movement in Thursday's pre-market session. Gainers included Intelligent Bio Solutions (INBS), OncoCyte (OCX), ZyVersa Therapeutics (ZVSA), CareDx (CDNA), Lipella Pharmaceuticals (LIPO), and Alaunos Therapeutics (TCRT). Losers included Atara Biotherapeutics (ATRA), Assertio Holdings (ASRT), Akili (AKLI), Amylyx Pharma (AMLX), Kazia Therapeutics (KZIA), and Ontrak (OTRK).

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:06 pm

ASTR

AWIN

BYU

CBAT

ESGL

ILAG

JAN

JCSE

SMR

THR

During Thursday's pre-market session, several industrials stocks experienced significant movement. Gainers included Astra Space (ASTR), JanOne (JAN), ESGL Holdings (ESGL), Bloom Energy (BE), Thermon Group Holdings (THR), and CBAK Energy Tech (CBAT). Losers included NuScale Power (SMR), Baiyu Holdings (BYU), Desktop Metal (DM), AERWINS Technologies (AWIN), Intelligent Living (ILAG), and JE Cleantech Hldgs (JCSE).

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:06 pm

APP

APPS

ARBK

ASTI

BILL

CYN

EBIX

EXFY

RAMP

RBT

SAI

SDIG

Several information technology stocks showed significant movement in Thursday's pre-market session. Expensify, Ascent Solar Technologies, Stronghold Digital Mining, AppLovin, LiveRamp Holdings, and Argo Blockchain were among the gainers, while Ebix, Rubicon Technologies, Digital Turbine, SAI.TECH Global, BILL Holdings, and Cyngn were among the losers.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:06 pm

ROLL

RBC Bearings has projected its Q3 FY24 revenue to be between $370M-$380M, compared to the estimated $383M. The company also expects its FY24 sales to be around $1.55B-$1.60B, slightly lower than the estimated $1.6B. The company's Q3 sales are expected to grow by 5.2% to 8.1% compared to last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:04 pm

BSGM

BioSig Technologies, Inc. (BSGM) has announced a registered direct offering priced at-the-market under Nasdaq rules. The offering is worth $2.5 million.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:02 pm

COLL

Collegium Pharmaceutical, Inc. has announced a $25 million accelerated share repurchase (ASR) program. The ASR is expected to be funded from the company's existing cash on hand.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:00 pm

ESS

Analysts have provided various ratings for Essex Property Trust (NYSE:ESS) within the last quarter, with 1 bullish, 1 somewhat bullish, and 7 indifferent. The average price target is $246.89, implying an upside from the current price of $210.88. This average represents a 1.02% decrease from the previous average price target of $249.43.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:00 pm

PYCR

Analysts have provided various ratings for Paycor HCM (NASDAQ:PYCR) within the last quarter, with 3 bullish, 1 somewhat bullish, and 7 indifferent. The average 12-month price target for Paycor HCM is $28.0, unchanged from the previous average.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:00 pm

GILD

Over the past 3 months, 4 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. The company has an average price target of $83.0, a decrease of 5.68% from the previous average price target of $88.00. The ratings include 2 bullish, 1 indifferent, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:00 pm

RXRX

Recursion Pharmaceuticals (NASDAQ:RXRX) reported Q3 earnings, missing estimated earnings by 13.16% with an EPS of $-0.43 versus an estimate of $-0.38. Revenue was down $2.63 million from the same period last year. Last quarter, the company also missed on EPS by $0.01, which was followed by a 5.02% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:00 pm